CHEMORADIOTHERAPY
Clinical trials for CHEMORADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new CHEMORADIOTHERAPY trials appear
Sign up with your email to follow new studies for CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (PD-1 inhibitor) to a standard treatment plan (short-course radiation, chemotherapy, and a targeted therapy) can improve outcomes for people with locally advanced rectal cancer. About 104 adults with a specific type of rectal …
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 05:16 UTC
-
Promising new combo aims to extend survival in lung cancer patients
Disease control Recruiting nowThis study tests whether adding two drugs, toripalimab and surufatinib, to standard chemoradiotherapy can help people with limited-stage small cell lung cancer live longer without the disease getting worse. About 47 adults aged 18 to 75 with stage I to III small cell lung cancer …
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New drug aims to protect cancer patients from chemo side effect
Disease control Recruiting nowThis study tests whether mecapegfilgrastim can safely prevent moderate-to-severe low blood cell counts (myelosuppression) caused by chemotherapy and radiation in people with lung or esophageal cancer. About 30 adults aged 18-75 will receive the drug and be monitored for side effe…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Breakthrough trial may let rectal cancer patients keep their rectum
Disease control Recruiting nowThis study tests whether a treatment plan called total neoadjuvant therapy (TNT) can help about half of rectal cancer patients avoid surgery and keep their rectum. Participants receive chemotherapy and radiation before deciding if they need surgery. Those who respond very well ar…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for hard-to-treat esophageal cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the drug surufatinib to standard chemotherapy, immunotherapy, and radiation can help people with advanced esophageal cancer that cannot be surgically removed. About 69 adults with this type of cancer will receive the combination treatment. The goal…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug combo aims to stop esophageal cancer relapse after standard treatment
Disease control Recruiting nowThis phase 3 trial tests whether adding two drugs—toripalimab (an immunotherapy) and capecitabine (a chemotherapy pill)—after standard chemoradiation can prevent esophageal cancer from coming back. About 242 adults with advanced esophageal cancer that hasn't progressed after init…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Can better nutrition improve cancer survival? major study launches
Knowledge-focused Recruiting nowThis study follows over 1,500 cancer patients in China to see how their nutritional status during chemotherapy and radiation affects their quality of life, treatment side effects, and survival. Researchers will track changes in diet, weight, and blood markers over time. The goal …
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Xiaoqin Luo • Aim: Knowledge-focused
Last updated May 26, 2026 05:22 UTC
-
Nationwide audit to ensure cervical cancer patients get the right treatment
Knowledge-focused Recruiting nowThis study looks at whether hospitals in India are following standard guidelines for treating cervical cancer with radiation and chemotherapy. Researchers will review records from over 600 patients across many hospitals to see how often the recommended treatment is given correctl…
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC